These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15199733)

  • 21. Management of dystonia of the lateral pterygoid muscle with botulinum toxin A.
    Mendes RA; Upton LG
    Br J Oral Maxillofac Surg; 2009 Sep; 47(6):481-3. PubMed ID: 18829144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of spasmotic torticollis with botulinum toxin A. A 5-year experience].
    Borgmann R
    Tidsskr Nor Laegeforen; 1997 May; 117(13):1889-91. PubMed ID: 9214007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Botulinum toxin type A therapy in a patient with cervical dystonia and amyotrophic lateral sclerosis.
    Singer C; Papapetropaulos S; Ayyar DR; Verma A
    Mov Disord; 2007 Jan; 22(2):289. PubMed ID: 17094101
    [No Abstract]   [Full Text] [Related]  

  • 24. [Frequency of side effects after botulinum toxin A injections in neurology, rehabilitation and gastroenterology].
    Sławek J; Madaliński MH; Maciag-Tymecka I; Duzyński W
    Pol Merkur Lekarski; 2005 Mar; 18(105):298-302. PubMed ID: 15997637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Botulinum toxin A in the management of focal muscle overactivity in children with cerebral palsy.
    Gibson N; Graham HK; Love S
    Disabil Rehabil; 2007 Dec; 29(23):1813-22. PubMed ID: 18033606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors affecting the health-related quality of life of patients with cervical dystonia and the impact of botulinum toxin type A injections.
    Slawek J; Friedman A; Potulska A; Krystkowiak P; Gervais C; Banach M; Ochudlo S; Budrewicz S; Reclawowicz D; Rynkowski M; Opala G
    Funct Neurol; 2007; 22(2):95-100. PubMed ID: 17637212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lingual protrusion dystonia: frequency, etiology and botulinum toxin therapy.
    Esper CD; Freeman A; Factor SA
    Parkinsonism Relat Disord; 2010 Aug; 16(7):438-41. PubMed ID: 20494607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapy of dystonia in Japan].
    Mezaki T; Hayashi A; Nakase H; Hasegawa K
    Rinsho Shinkeigaku; 2005 Sep; 45(9):634-42. PubMed ID: 16248394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Botulinum toxin and neuromotor rehabilitation: An integrated approach to idiopathic cervical dystonia.
    Tassorelli C; Mancini F; Balloni L; Pacchetti C; Sandrini G; Nappi G; Martignoni E
    Mov Disord; 2006 Dec; 21(12):2240-3. PubMed ID: 17029278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study.
    Truong D; Duane DD; Jankovic J; Singer C; Seeberger LC; Comella CL; Lew MF; Rodnitzky RL; Danisi FO; Sutton JP; Charles PD; Hauser RA; Sheean GL
    Mov Disord; 2005 Jul; 20(7):783-91. PubMed ID: 15736159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The combined use of forced cold air and topical anesthetic cream for analgesia during the treatment of palmar hyperhydrosis with botulinum toxin injections.
    Patel R; Halem M; Zaiac M
    J Drugs Dermatol; 2009 Oct; 8(10):948-51. PubMed ID: 19852126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Botulinum neurotoxin A: an unusual systemic effect.
    Howell K; Selber P; Graham HK; Reddihough D
    J Paediatr Child Health; 2007 Jun; 43(6):499-501. PubMed ID: 17535186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics.
    Schmid DM; Sauermann P; Werner M; Schuessler B; Blick N; Muentener M; Strebel RT; Perucchini D; Scheiner D; Schaer G; John H; Reitz A; Hauri D; Schurch B
    J Urol; 2006 Jul; 176(1):177-85. PubMed ID: 16753396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduction of salivary flow with botulinum toxin: extended report on 33 patients with drooling, salivary fistulas, and sialadenitis.
    Ellies M; Gottstein U; Rohrbach-Volland S; Arglebe C; Laskawi R
    Laryngoscope; 2004 Oct; 114(10):1856-60. PubMed ID: 15454785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Botulinum toxin type A in the treatment of neuropathic pain in a case of postherpetic neuralgia].
    Ruiz Huete C; Bermejo P
    Neurologia; 2008 May; 23(4):259-62. PubMed ID: 18516748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Botulinum toxin injection for congenital muscular torticollis presenting in children and adults.
    Collins A; Jankovic J
    Neurology; 2006 Sep; 67(6):1083-5. PubMed ID: 17000985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complications of botulinum toxin A use in facial rejuvenation.
    Vartanian AJ; Dayan SH
    Facial Plast Surg Clin North Am; 2005 Feb; 13(1):1-10. PubMed ID: 15519923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clostridium botulinum type A toxin for the treatment of upper face animation lines: an Iranian experience.
    Farahvash MR; Arad S
    J Cosmet Dermatol; 2007 Sep; 6(3):152-8. PubMed ID: 17760691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of 3- and 5-injection patterns (30 and 50 U) of botulinum toxin A (Dysport) for the treatment of wrinkles in the glabella and the central forehead region.
    Rzany B; Ascher B; Fratila A; Monheit GD; Talarico S; Sterry W
    Arch Dermatol; 2006 Mar; 142(3):320-6. PubMed ID: 16549707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Persistent injury to an ocular motor muscle secondary to injection of botulinum toxin].
    Gómez-Argüelles JM; Sebastián-de la Cruz F
    Rev Neurol; 2008 Mar 1-15; 46(5):318-9. PubMed ID: 18351572
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.